BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reiter RJ, Sharma R, Rosales-Corral S. Anti-Warburg Effect of Melatonin: A Proposed Mechanism to Explain its Inhibition of Multiple Diseases. Int J Mol Sci 2021;22:E764. [PMID: 33466614 DOI: 10.3390/ijms22020764] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Loh D, Reiter RJ. Melatonin: Regulation of Biomolecular Condensates in Neurodegenerative Disorders. Antioxidants (Basel) 2021;10:1483. [PMID: 34573116 DOI: 10.3390/antiox10091483] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kim SH, Baek KH. Regulation of Cancer Metabolism by Deubiquitinating Enzymes: The Warburg Effect. Int J Mol Sci 2021;22:6173. [PMID: 34201062 DOI: 10.3390/ijms22126173] [Reference Citation Analysis]
3 Marinkovic DZ, Medar MLJ, Becin AP, Andric SA, Kostic TS. Growing Up Under Constant Light: A Challenge to the Endocrine Function of the Leydig Cells. Front Endocrinol (Lausanne) 2021;12:653602. [PMID: 33796081 DOI: 10.3389/fendo.2021.653602] [Reference Citation Analysis]
4 Samec M, Liskova A, Koklesova L, Zhai K, Varghese E, Samuel SM, Šudomová M, Lucansky V, Kassayova M, Pec M, Biringer K, Brockmueller A, Kajo K, Hassan STS, Shakibaei M, Golubnitschaja O, Büsselberg D, Kubatka P. Metabolic Anti-Cancer Effects of Melatonin: Clinically Relevant Prospects. Cancers (Basel) 2021;13:3018. [PMID: 34208645 DOI: 10.3390/cancers13123018] [Reference Citation Analysis]
5 Reiter RJ, Sharma R, Simko F, Dominguez-rodriguez A, Tesarik J, Neel RL, Slominski AT, Kleszczynski K, Martin-gimenez VM, Manucha W, Cardinali DP. Melatonin: highlighting its use as a potential treatment for SARS-CoV-2 infection. Cell Mol Life Sci 2022;79. [DOI: 10.1007/s00018-021-04102-3] [Reference Citation Analysis]
6 Li M, Hao B, Zhang M, Reiter RJ, Lin S, Zheng T, Chen X, Ren Y, Yue L, Abay B, Chen G, Xu X, Shi Y, Fan L. Melatonin enhances radiofrequency-induced NK antitumor immunity, causing cancer metabolism reprogramming and inhibition of multiple pulmonary tumor development. Signal Transduct Target Ther 2021;6:330. [PMID: 34471091 DOI: 10.1038/s41392-021-00745-7] [Reference Citation Analysis]
7 Reiter RJ, Sharma R, Rosales-Corral S, de Campos Zuccari DAP, de Almeida Chuffa LG. Melatonin: A mitochondrial resident with a diverse skill set. Life Sci 2022;:120612. [PMID: 35523285 DOI: 10.1016/j.lfs.2022.120612] [Reference Citation Analysis]
8 Cesário RC, Gaiotte LB, Cucielo MS, Silveira HS, Dos Santos LD, de Campos Zuccari DAP, Seiva FRF, Reiter RJ, de Almeida Chuffa LG. The proteomic landscape of ovarian cancer cells in response to melatonin. Life Sci 2022;:120352. [PMID: 35074409 DOI: 10.1016/j.lfs.2022.120352] [Reference Citation Analysis]
9 Mu Q, Najafi M. Modulation of the tumor microenvironment (TME) by melatonin. Eur J Pharmacol 2021;907:174365. [PMID: 34302814 DOI: 10.1016/j.ejphar.2021.174365] [Reference Citation Analysis]
10 Novais AA, Chuffa LGA, Zuccari DAPC, Reiter RJ. Exosomes and Melatonin: Where Their Destinies Intersect. Front Immunol 2021;12:692022. [PMID: 34177952 DOI: 10.3389/fimmu.2021.692022] [Reference Citation Analysis]
11 Xiao Y, Phelp P, Wang Q, Bakker D, Nederlof R, Hollmann MW, Zuurbier CJ. Cardioprotecive Properties of Known Agents in Rat Ischemia-Reperfusion Model Under Clinically Relevant Conditions: Only the NAD Precursor Nicotinamide Riboside Reduces Infarct Size in Presence of Fentanyl, Midazolam and Cangrelor, but Not Propofol. Front Cardiovasc Med 2021;8:712478. [PMID: 34527711 DOI: 10.3389/fcvm.2021.712478] [Reference Citation Analysis]
12 Pan S, Guo Y, Hong F, Xu P, Zhai Y. Therapeutic potential of melatonin in colorectal cancer: Focus on lipid metabolism and gut microbiota. Biochim Biophys Acta Mol Basis Dis 2022;1868:166281. [PMID: 34610472 DOI: 10.1016/j.bbadis.2021.166281] [Reference Citation Analysis]
13 Romero A, Ramos E, López-Muñoz F, De Los Ríos C, Egea J, Gil-Martín E, Pita R, Torrado JJ, Serrano DR, Juberias A. Toxicology of Blister Agents: Is Melatonin a Potential Therapeutic Option? Diseases 2021;9:27. [PMID: 33920224 DOI: 10.3390/diseases9020027] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Reiter RJ, Sharma R, Rosales-Corral S, Manucha W, Chuffa LGA, Zuccari DAPC. Melatonin and Pathological Cell Interactions: Mitochondrial Glucose Processing in Cancer Cells. Int J Mol Sci 2021;22:12494. [PMID: 34830375 DOI: 10.3390/ijms222212494] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Reiter RJ, Sharma R, Rodriguez C, Martin V, Rosales-Corral S, Zuccari DAPC, Chuffa LGA. Part-time cancers and role of melatonin in determining their metabolic phenotype. Life Sci 2021;278:119597. [PMID: 33974932 DOI: 10.1016/j.lfs.2021.119597] [Cited by in F6Publishing: 1] [Reference Citation Analysis]